Being fair to participants in placebo-controlled COVID-19 vaccine trials

Nat Med. 2021 Jun;27(6):938. doi: 10.1038/s41591-021-01338-1.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / epidemiology
  • COVID-19 / immunology
  • COVID-19 / prevention & control*
  • COVID-19 / virology
  • COVID-19 Vaccines / immunology
  • COVID-19 Vaccines / therapeutic use*
  • Drug Approval
  • Humans
  • SARS-CoV-2 / pathogenicity
  • United States / epidemiology
  • United States Food and Drug Administration
  • Vaccination*
  • World Health Organization

Substances

  • COVID-19 Vaccines